A novel BRCA1 mutation in an identical twin pair with similar clinical histories

Cancer Genetics and Cytogenetics

Volumn 100, Issue 1, 1998, Pages 43-48

  Miesfeldt, Susan ^a   Turner, Beverely L ^a   Lovell, Mark A ^a   Cooper, Michael R ^a   Lescallett, Jennifer ^c   Jones, Susan M ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Oncormed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE REPORT; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MONOZYGOTIC TWINS; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031983683     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00006-X     Document Type: Article

References (9)

1. 1. Easton DF, Bishop DT, Crockford GP, the Breast Cancer Linkage Consortium (1993): Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52:678-701.
2. 2. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, the Breast Cancer Linkage Consortium (1994): Risk of cancer in BRCA1 mutation carriers. Lancet 343:692-695.
3. 3. Easton DF, Narod SA, Ford D, Steel M (1994): The genetic epidemiology of BRCA1. Lancet 344:761.
4. 4. Miller SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
5. 5. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King M-C, Goldgar DE (1996): Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet 58:271-280.
6. 6. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King M-C, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH, Goldgar DE (1995): A collaborative study of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273:535-541.
7. 7. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ (1995): Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet 11:428-433.
8. 8. Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BAJ, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA (1996): Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genet 12:309-311.
9. 9. Narod SA, Goldgar D, Cannon-Albright L, Complete list of authors (1995): Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64:394-398.